Abstract

In the course of circulation erythrocytes can test damages, which compromises their integrity and thus triggers suicidal erythrocyte death or eryptosis. This mechanism is characterised by cell shrinkage, cell membrane blebbing, and cell membrane phospholipid scrambling after phosphatidylserine exposure on the cell surface that is identified by macrophages, which engulf and degrade the eryptotic cells. The term eryptosis also includes typical mechanisms, which contribute to the triggering of this process, such as oxidative stress, Ca2+ entry with an increase in cytosolic Ca2+ activity and the activation of p38 kinase, which is a kinase expressed in human erythrocytes and activated after hyperosmotic shock. Enhanced eryptosis has been observed in several clinical conditions such as diabetes, renal insufficiency, haemolytic uremic syndrome, sepsis, mycoplasma infection, malaria, iron deficiency, sickle cell anaemia, beta-thalassemia, glucose-6-phosphate dehydrogenase (G6PD)-deficiency, hereditary spherocytosis, paroxysmal nocturnal haemoglobinuria, Wilson’s disease, myelodysplastic syndrome, and phosphate depletion. Therefore, eryptosis may be considered as a useful mechanism of removal of defective erythrocytes to prevent haemolysis. Moreover, the clearance of infected erythrocytes in diseases such as malaria may counteract parasitemia. Indeed it is known that sickle-cell trait, beta-thalassemia trait, G6PD-deficiency and iron deficiency confer some protection against a severe course of malaria. Importantly, strategies to control Plasmodium infection by inducing eryptosis are not expected to generate resistance of the pathogen, as the proteins involved in suicidal death of the host cell are not encoded by the pathogen and thus cannot be modified by mutations of its genes. However, excessive eryptosis could compromise microcirculation and lead to anemia. Besides, adhesion of eryptosis erythrocytes to a vascular wall also can lead to microcirculation infringement.Thus, modern representations about eryptosis expand our knowledge about the programmed death of blood cells and is more directed to create new therapeutic schemes of treatment of patients.

Highlights

  • В ходе кровообращения эритроциты могут повреждаться, что ставит под угрозу их целостность и вызывает программированную смерть эритроцита, или эриптоз

  • In the course of circulation erythrocytes can test damages, which compromises their integrity and triggers suicidal erythrocyte death or eryptosis. This mechanism is characterised by cell shrinkage, cell membrane blebbing, and cell membrane phospholipid scrambling after phosphatidylserine exposure on the cell surface that is identified by macrophages, which engulf and degrade the eryptotic cells

  • The term eryptosis includes typical mechanisms, which contribute to the triggering of this process, such as oxidative stress, Ca2+ entry with an increase in cytosolic Ca2+ activity and the activation of p38 kinase, which is a kinase expressed in human erythrocytes and activated after hyperosmotic shock

Read more

Summary

НАУчНЫЕ ОБЗОРЫ

In the course of circulation erythrocytes can test damages, which compromises their integrity and triggers suicidal erythrocyte death or eryptosis. This mechanism is characterised by cell shrinkage, cell membrane blebbing, and cell membrane phospholipid scrambling after phosphatidylserine exposure on the cell surface that is identified by macrophages, which engulf and degrade the eryptotic cells. Однако исследования последних 20 лет, проведенные на эритроцитах человека и других млекопитающих, показали, что ряд событий, характерных для апоптоза, можно обнаружить в тромбоцитах и эритроцитах — клетках, лишенных ядра [9]. С другой стороны, при эриптозе проявляются некоторые другие важные черты апоптоза, такие как ускоренное уменьшение объема клетки, везикуляция и скрамблирование клеточной мембраны, ведущие к перемещению фосфатидилсерина из внутреннего слоя мембраны на поверхность клетки [186]. В обзорной статье обсуждаются современные представления о молекулярных механизмах эриптоза (мембраносвязанного апоптоза) в эритроцитах человека в норме и при патологии

Распространенность Индукция Генный контроль Морфологические параметры
Активируется физиологическими или патологическими стимулами
Появление фосфатидилхолина
Структурные и биофизические характеристики эритроцитов
Àíêèðèíîâûé êîìïëåêñ
Метаболические особенности эритроцита человека
МОЛЕКУЛЯРНЫЕ МЕХАНИЗМЫ ПРОЦЕССА ЭРИПТОЗА
Окислительный стресс
ФС ФС ФС
Индукция уменьшения объема клетки
Взаимодействие этих рецепторов замедляет фагоцитоз
Угнетающее действие нитратов
Findings
Гемолиз Ретикулоциты
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call